Page last updated: 2024-11-05

ferbam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ferbam: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ferbam : A dithiocarbamate salt that is the iron(III) salt of dimethyldithiocarbamic acid. Formerly used as a fungicide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID86289068
CHEBI ID5015
MeSH IDM0057402

Synonyms (19)

Synonym
trimanzone
hexaferb
tris(n,n-dimethyldithiocarbamato)iron(iii)
cormate
fermacide
fermate
hokmate
karbam black
iron(iii) dimethyldithiocarbamate
trifungol
ferradow
fuklasin
14484-64-1
ferbam
eisendimethyldithiocarbamat
ferbeck
iron(3+) dimethyldithiocarbamate
iron(3+) tris(dimethylcarbamodithioate)
CHEBI:5015

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"We previously determined that the dithiocarbamate pesticide sodium metam (NaM) and its active ingredient methylisothiocyanate (MITC) were developmentally toxic causing notochord distortions in the zebrafish."( Dithiocarbamates have a common toxic effect on zebrafish body axis formation.
Alzarban, N; La Du, JK; Tanguay, RL; Tilton, F; Vue, M, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (39.29)18.7374
1990's3 (10.71)18.2507
2000's8 (28.57)29.6817
2010's2 (7.14)24.3611
2020's4 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]